Zene
Latest round
- Seed
Last raised
- Mar 2021
Total raised
- $0.5M
Investors
- 1
About Zene
Based in Japan, established in 2020, Zene Inc. offers innovative genomic analysis services, enhancing individual health insights through accessible genetic testing solutions.Zene Inc. is a Tokyo-based company that specializes in genomic analysis services. It was founded in 2020 and has completed three investment deals to date. Zene Inc. has not undergone any pivots in strategy or operations since its inception. The company was founded by a team of individuals, although specific names are not available.Zene Inc. specializes in advanced genomic analysis services, primarily through its flagship product, Zene360. This service enables users to collect saliva samples conveniently at home for low-cost genetic testing, which provides insights into lifelong genetic information. By visualizing immutable genome data, Zene360 helps users uncover their unique individual traits and health predispositions. The company targets health insurance unions and municipalities, offering tailored genomic information that aids in preventative health measures and reducing healthcare expenditures.Zene Inc. generates revenue primarily through its genomic analysis services, structured as direct-to-consumer offerings and partnerships with health insurance providers. Clients engage in transactions that involve subscriptions for ongoing services or one-time fees for individual genomic analysis, such as the Zene360 service. The pricing structure associated with these services reflects a commitment to affordability while catering to the needs of both consumers and corporate clients. The company emphasizes the value of its genomic insights in transforming healthcare expenses from costs into investments that promote proactive health management.In March 2024, Zene Inc. Zene Inc. is working on designing new products aimed at further enhancing its genomic testing services, although specific release dates are not disclosed. Additionally, there are intentions to expand into new markets, with a focus on enhancing services to municipalities and health insurance unions outside of Japan.
Who invested in Zene
1 investor across 1 round
See all investors in Zene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 8, 2021
Amount
$0.5M
Investors
Questions about Zene
Who invested in Zene?
Zene has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zene raised?
Zene has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Zene last raise money?
Zene's most recent round on record is a Seed, in Mar 2021.
What does Zene do?
Based in Japan, established in 2020, Zene Inc.
Where is Zene headquartered?
Zene is headquartered in Tokyo, Japan.
Which VCs invest in companies like Zene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Zene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Zene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.